Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In Vivo

Tumor antigen–encoding mRNA for dendritic cell (DC)-based vaccination has gained increasing popularity in recent years. Within this context, two main strategies have entered the clinical trial stage: the use of mRNA for ex vivo antigen loading of DCs and the direct application of mRNA as a source of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Benteyn, Daphné, Anguille, Sébastien, Van Lint, Sandra, Heirman, Carlo, Van Nuffel, An MT, Corthals, Jurgen, Ochsenreither, Sebastian, Waelput, Wim, Van Beneden, Katrien, Breckpot, Karine, Van Tendeloo, Viggo, Thielemans, Kris, Bonehill, Aude
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2013
Sujets:
Methods - Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3889186/
https://ncbi.nlm.nih.gov/pubmed/24253259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtna.2013.54
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires